Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-017310
Filing Date
2021-03-03
Accepted
2021-03-03 19:00:28
Documents
1
Period of Report
2021-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4224
  Complete submission text file 0001209191-21-017310.txt   5675
Mailing Address 1825 K STREET SUITE 510 WASHINGTON DC 20006
Business Address
Cross Shawn (Reporting) CIK: 0001734779 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39306 | Film No.: 21711464

Mailing Address 1 TOWER PLACE, SUITE 850 SOUTH SAN FRANCISCO CA 94080
Business Address 1 TOWER PLACE, SUITE 850 SOUTH SAN FRANCISCO CA 94080 650-392-0420
Applied Molecular Transport Inc. (Issuer) CIK: 0001801777 (see all company filings)

EIN.: 814481426 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations